Literature DB >> 18094169

Stabilization of TM trimer interactions during activation of moloney murine leukemia virus Env.

Mathilda Sjöberg1, Birgitta Lindqvist, Henrik Garoff.   

Abstract

The transmembrane subunit (TM) of the trimeric retrovirus Env complex is thought to direct virus-cell membrane fusion by refolding into a cell membrane-interacting, extended form that subsequently folds back on itself into a very stable trimer of hairpin-like TM polypeptides. However, so far there is only limited evidence for the formation of a stable TM trimer during Env activation. Here we have studied the oligomer composition and stability of an intermediate and the fully activated form of Moloney murine leukemia virus (Mo-MLV) Env. Activation of Mo-MLV Env is controlled by isomerization of its intersubunit disulfide. This results in surface subunit (SU) dissociation and TM refolding. If activation is done in the presence of an alkylator, this will modify the isomerization-active thiol in the SU of Env and arrest Env at an intermediate stage, the isomerization-arrested state (IAS) of its activation pathway. We generated IAS and fully activated Envs in vitro and in vivo and studied their states of oligomerization by two-dimensional blue native polyacrylamide gel electrophoresis (PAGE) and nonreducing sodium dodecyl sulfate (SDS)-PAGE. The IAS Env was composed of trimers of SU-TM complexes, whereas the activated Env consisted of SU monomers and TM trimers. When the oligomers were subjected to mild SDS treatment the TM trimer was found to be 3.5 times more resistant than the IAS oligomer. Thus, this demonstrates that a structural conversion of TM takes place during activation, which results in the formation of a stable TM trimer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18094169      PMCID: PMC2258960          DOI: 10.1128/JVI.01931-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins.

Authors:  B Kobe; R J Center; B E Kemp; P Poumbourios
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

2.  The fusion-controlling disulfide bond isomerase in retrovirus Env is triggered by protein destabilization.

Authors:  Michael Wallin; Maria Ekström; Henrik Garoff
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes.

Authors:  A Pinter; R Kopelman; Z Li; S C Kayman; D A Sanders
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Core structure of gp41 from the HIV envelope glycoprotein.

Authors:  D C Chan; D Fass; J M Berger; P S Kim
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

5.  Retrovirus envelope protein complex structure in situ studied by cryo-electron tomography.

Authors:  Friedrich Förster; Ohad Medalia; Nathan Zauberman; Wolfgang Baumeister; Deborah Fass
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-17       Impact factor: 11.205

6.  Influenza hemagglutinin is spring-loaded by a metastable native conformation.

Authors:  C M Carr; C Chaudhry; P S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

7.  Capture of an early fusion-active conformation of HIV-1 gp41.

Authors:  R A Furuta; C T Wild; Y Weng; C D Weiss
Journal:  Nat Struct Biol       Date:  1998-04

8.  Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.

Authors:  Robert C Netter; Sean M Amberg; John W Balliet; Mark J Biscone; Arwen Vermeulen; Laurie J Earp; Judith M White; Paul Bates
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

9.  Inhibition of cell-free human T-cell leukemia virus type 1 infection at a postbinding step by the synthetic peptide derived from an ectodomain of the gp21 transmembrane glycoprotein.

Authors:  A Jinno; Y Haraguchi; H Shiraki; H Hoshino
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

10.  Moloney murine leukemia virus envelope protein subunits, gp70 and Pr15E, form a stable disulfide-linked complex.

Authors:  D J Opstelten; M Wallin; H Garoff
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

View more
  6 in total

1.  Maturation cleavage of the murine leukemia virus Env precursor separates the transmembrane subunits to prime it for receptor triggering.

Authors:  Robin Löving; Shang-Rung Wu; Mathilda Sjöberg; Birgitta Lindqvist; Henrik Garoff
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

2.  Cooperative cleavage of the R peptide in the Env trimer of Moloney murine leukemia virus facilitates its maturation for fusion competence.

Authors:  Robin Löving; Malin Kronqvist; Mathilda Sjöberg; Henrik Garoff
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

3.  Sequential activation of the three protomers in the Moloney murine leukemia virus Env.

Authors:  Mathilda Sjöberg; Robin Löving; Birgitta Lindqvist; Henrik Garoff
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-21       Impact factor: 11.205

4.  Receptor binding and low pH coactivate oncogenic retrovirus envelope-mediated fusion.

Authors:  Marceline Côté; Yi-Min Zheng; Shan-Lu Liu
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

5.  Turning of the receptor-binding domains opens up the murine leukaemia virus Env for membrane fusion.

Authors:  Shang-Rung Wu; Mathilda Sjöberg; Michael Wallin; Birgitta Lindqvist; Maria Ekström; Hans Hebert; Philip J B Koeck; Henrik Garoff
Journal:  EMBO J       Date:  2008-09-18       Impact factor: 11.598

Review 6.  Reverse Engineering Provides Insights on the Evolution of Subgroups A to E Avian Sarcoma and Leukosis Virus Receptor Specificity.

Authors:  Mark J Federspiel
Journal:  Viruses       Date:  2019-05-30       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.